In Silico Elucidation of Deleterious Non-synonymous SNPs in SHANK3, the Autism Spectrum Disorder Gene.


Journal

Journal of molecular neuroscience : MN
ISSN: 1559-1166
Titre abrégé: J Mol Neurosci
Pays: United States
ID NLM: 9002991

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 01 12 2019
accepted: 13 04 2020
pubmed: 11 6 2020
medline: 30 6 2021
entrez: 11 6 2020
Statut: ppublish

Résumé

SHANK3, a member of SH3 and multiple ankyrin repeat domains (SHANK) proteins, plays a crucial role in synaptic development and functions. Mutations in SHANK3 have been linked to a number of neuropsychiatric and neurodevelopmental disorders, including autism spectrum disorder. In this study, the functional and structural impacts of non-synonymous single-nucleotide polymorphisms (SNPs) on SHANK3 were predicted. Various databases were used to extract 16,894 non-redundant SNPs, out of which 1179 were annotated as missense variants. Missense variants were categorized as deleterious or non-deleterious. Twenty-nine missense variants were unanimously recognized as deleterious and subjected to structural and stability analyses. Mutations, including L47P, G54W, G172D, G250C/D, and G627E, which posed drastic effects on the secondary structure of SHANK3, were modeled. Stability analyses introduced L47P, G54W, and G250D as the most destabilizing mutations, thus they were subjected to molecular dynamics simulation. Simulation revealed significant changes in intramolecular interactions and high fluctuations in residues of 1-350 that significantly affect the ANK functional domain. G250C/D and G635R consensus deleterious mutations were found in the first and second binding domains of SHANK3, and none were found in the post-translational modification sites. This study suggests L47P, G54W, and G250C/D deleterious mutations as priorities for future studies on SHANK3.

Identifiants

pubmed: 32519210
doi: 10.1007/s12031-020-01552-5
pii: 10.1007/s12031-020-01552-5
doi:

Substances chimiques

Nerve Tissue Proteins 0
SHANK3 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1649-1667

Références

Abraham M, Van Der Spoel D, Lindahl E, Hess B (2014) The GROMACS development team GROMACS user manual Versio 5
Adzhubei IA et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7:248. https://doi.org/10.1038/nmeth0410-248
doi: 10.1038/nmeth0410-248 pubmed: 20354512 pmcid: 20354512
Alonso-Gonzalez A, Rodriguez-Fontenla C, Carracedo A (2018) De novo mutations (DNMs) in Autism Spectrum Disorder (ASD): pathway and network analysis Fgene 9. https://doi.org/10.3389/fgene.2018.00406
Baio J (2014) Prevalence of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2010 Morbidity and mortality weekly report Surveillance summaries (Washington, DC: 2002) 63:1
Baio J et al (2018) Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR Surveill Summ 67:1. https://doi.org/10.15585/mmwr.ss6706a1
doi: 10.15585/mmwr.ss6706a1 pubmed: 29701730 pmcid: 5919599
Blom N, Gammeltoft S, Brunak S (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites1. J Mol Biol 294:1351–1362. https://doi.org/10.1006/jmbi.1999.3310
doi: 10.1006/jmbi.1999.3310 pubmed: 10600390
Boccuto L et al (2013) Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders. Eur J Hum Genet 21:310. https://doi.org/10.1038/ejhg.2012.175
Brown JT, Eum S, Cook EH, Bishop JR (2017) Pharmacogenomics of autism spectrum disorder. Pharmacogenomics 18:403–414. https://doi.org/10.2217/pgs-2016-0167
doi: 10.2217/pgs-2016-0167 pubmed: 28244813
Calabrese R, Capriotti E, Fariselli P, Martelli PL, Casadio R (2009) Functional annotations improve the predictive score of human disease-related mutations in proteins. Hum Mutat 30:1237–1244. https://doi.org/10.1002/humu.21047
doi: 10.1002/humu.21047 pubmed: 19514061
Capriotti E, Calabrese R, Casadio R (2006) Predicting the insurgence of human genetic diseases associated to single point protein mutations with support vector machines and evolutionary information. Bioinformatics 22:2729–2734. https://doi.org/10.1093/bioinformatics/btl423
doi: 10.1093/bioinformatics/btl423 pubmed: 16895930
Capriotti E, Fariselli P, Casadio R (2005) I-Mutant2. 0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res 33:W306–W310. https://doi.org/10.1093/nar/gki375
doi: 10.1093/nar/gki375 pubmed: 15980478 pmcid: 1160136
Choi Y, Sims GE, Murphy S, Miller JR, Chan AP (2012) Predicting the functional effect of amino acid substitutions and indels. PLoS One 7:e46688. https://doi.org/10.1371/journal.pone.0046688
doi: 10.1371/journal.pone.0046688 pubmed: 23056405 pmcid: 3466303
De Baets G et al (2011) SNPeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants. Nucleic Acids Res 40:D935–D939. https://doi.org/10.1093/nar/gkr996
Dinkel H et al (2015) ELM 2016—data update and new functionality of the eukaryotic linear motif resource. Nucleic Acids Res 44:294–300. https://doi.org/10.1093/nar/gkv1291
doi: 10.1093/nar/gkv1291
Eisenberg D, Lüthy R, Bowie J (1997) VERIFY3D: assessment of protein models with three-dimensional profiles. In Methods in enzymology. vol 277. Academic Press. https://doi.org/10.1016/S0076-6879(97)77022-8
Gherardini PF, Helmer-Citterich M (2008) Structure-based function prediction: approaches and applications. Brief Funct Genomic Proteomic 7:291–302. https://doi.org/10.1093/bfgp/eln030
doi: 10.1093/bfgp/eln030 pubmed: 18599513
Hassan MS, Shaalan A, Dessouky M, Abdelnaiem AE, ElHefnawi M (2018) A review study: computational techniques for expecting the impact of non-synonymous single nucleotide variants in human diseases. Gene 680:20–33. https://doi.org/10.1016/j.gene.2018.09.028
doi: 10.1016/j.gene.2018.09.028 pubmed: 30240882
Hecht M, Bromberg Y, Rost B (2015) Better prediction of functional effects for sequence variants. BMC Genomics 16:S1. https://doi.org/10.1186/1471-2164-16-S8-S1
doi: 10.1186/1471-2164-16-S8-S1 pubmed: 26110438 pmcid: 4480835
Ishida H, Skorobogatov A, Yamniuk AP, Vogel HJ (2018) Solution structures of the SH 3 domains from Shank scaffold proteins and their interactions with Cav1. 3 calcium channels. FEBS Lett 592:2786–2797. https://doi.org/10.1002/1873-3468.13209
doi: 10.1002/1873-3468.13209 pubmed: 30058071
Johansen MB, Kiemer L, Brunak S (2006) Analysis and prediction of mammalian protein glycation. Glycobiol 16:844–853. https://doi.org/10.1093/glycob/cwl009
doi: 10.1093/glycob/cwl009
Källberg M, Margaryan G, Wang S, Ma J, Xu J (2014) RaptorX server: a resource for template-based protein structure modeling. In: Protein Structure Prediction. Springer, pp 17–27. https://doi.org/10.1007/978-1-4939-0366-5_2
Källberg M, Wang H, Wang S, Peng J, Wang Z, Lu H, Xu J (2012) Template-based protein structure modeling using the RaptorX web server. Nat Protoco 7:1511. https://doi.org/10.1038/nprot.2012.085
doi: 10.1038/nprot.2012.085
Laskowski RA, Jabłońska J, Pravda L, Vařeková RS, Thornton JM (2018) PDBsum: structural summaries of PDB entries. Prot Sci 27:129–134. https://doi.org/10.1002/pro.3289
doi: 10.1002/pro.3289
Leblond CS et al (2014) Meta-analysis of SHANK mutations in autism spectrum disorders: a gradient of severity in cognitive impairments. PLoS Genet 10:e1004580. https://doi.org/10.1371/journal.pgen.1004580
doi: 10.1371/journal.pgen.1004580 pubmed: 25188300 pmcid: 4154644
Lemonnier É et al (2012) A randomised controlled trial of bumetanide in the treatment of autism in children. Translat Psychiatry 2:e202. https://doi.org/10.1038/tp.2012.124
doi: 10.1038/tp.2012.124
Lilja J et al (2017) SHANK proteins limit integrin activation by directly interacting with Rap1 and R-Ras. Nat Cell Biol 19:292. https://doi.org/10.1038/ncb3487
doi: 10.1038/ncb3487 pubmed: 28263956 pmcid: 5386136
Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO, Shaw DE (2010) Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78:1950–1958. https://doi.org/10.1002/prot.22711
doi: 10.1002/prot.22711 pubmed: 20408171 pmcid: 2970904
Lobanov MY, Bogatyreva N, Galzitskaya O (2008) Radius of gyration as an indicator of protein structure compactness. J Mol Biol 42:623–628. https://doi.org/10.1134/S0026893308040195
doi: 10.1134/S0026893308040195
Lovell SC et al (2003) Structure validation by Cα geometry: ϕ, ψ and Cβ deviation. Proteins 50:437–450. https://doi.org/10.1002/prot.10286
doi: 10.1002/prot.10286 pubmed: 12557186
Marchler-Bauer A et al (2016) CDD/SPARCLE: functional classification of proteins via subfamily domain architectures. Nucleic Acids Res 45:D200–D203. https://doi.org/10.1093/nar/gkw1129
doi: 10.1093/nar/gkw1129 pubmed: 27899674 pmcid: 5210587
Mashayekhi F, Mizban N, Bidabadi E, Salehi Z (2016) The association of SHANK3 gene polymorphism and autism. Minerva pediatrica
Monteiro P, Feng G (2017) SHANK proteins: roles at the synapse and in autism spectrum disorder. Nat Rev Neurosci 18:147–157. https://doi.org/10.1038/nrn.2016.183
doi: 10.1038/nrn.2016.183 pubmed: 28179641
Nia FH, Kreienkamp H-J (2018) Functional relevance of missense mutations affecting the N-terminal part of Shank3 found in autistic patients. Front Mol Neurosci 11 https://doi.org/10.3389/fnmol.2018.00268
Peça J et al (2011a) Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472:437. https://doi.org/10.1038/nature09965
doi: 10.1038/nature09965 pubmed: 21423165 pmcid: 3090611
Peça J, Ting J, Feng G (2011b) SnapShot: autism and the synapse. Cell 147:706–706. e701
doi: 10.1016/j.cell.2011.10.015
Pejaver V et al. (2017) MutPred2: inferring the molecular and phenotypic impact of amino acid variants BioRxiv:134981 https://doi.org/10.1101/134981
Petersen B, Petersen TN, Andersen P, Nielsen M, Lundegaard C (2009) A generic method for assignment of reliability scores applied to solvent accessibility predictions. BMC Struct Biol 9:51. https://doi.org/10.1186/1472-6807-9-51
doi: 10.1186/1472-6807-9-51 pubmed: 19646261 pmcid: 2725087
Piao L, Chen Z, Li Q, Liu R, Song W, Kong R, Chang S (2019) Molecular dynamics simulations of wild type and mutants of SAPAP in Complexed with Shank3. MDPI 20:224. https://doi.org/10.3390/ijms20010224
doi: 10.3390/ijms20010224
Qiu S et al (2018) Association between SHANK3 polymorphisms and susceptibility to autism spectrum disorder. Gene 651:100–105. https://doi.org/10.1016/j.gene.2018.01.078
doi: 10.1016/j.gene.2018.01.078 pubmed: 29408620
Quan L, Lv Q, Zhang Y (2016) STRUM: structure-based prediction of protein stability changes upon single-point mutation. Bioinformatics 32:2936–2946. https://doi.org/10.1093/bioinformatics/btw361
doi: 10.1093/bioinformatics/btw361 pubmed: 27318206 pmcid: 5039926
Radivojac P et al (2010) Identification, analysis, and prediction of protein ubiquitination sites. Proteins 78:365–380. https://doi.org/10.1002/prot.22555
doi: 10.1002/prot.22555 pubmed: 19722269 pmcid: 3006176
Rodrigues CH, Pires DE, Ascher DB (2018) DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Res 46:W350–W355. https://doi.org/10.1093/nar/gky300
doi: 10.1093/nar/gky300 pubmed: 29718330 pmcid: 6031064
Rodriguez-Casado A (2012) In silico investigation of functional nsSNPs an approach to rational drug design. Res Rep Med Chem 2:31–42. https://doi.org/10.2147/RRMC.S28211
Sala C, Vicidomini C, Bigi I, Mossa A, Verpelli C (2015) Shank synaptic scaffold proteins: keys to understanding the pathogenesis of autism and other synaptic disorders. J Neurochem 135:849–858. https://doi.org/10.1111/jnc.13232
doi: 10.1111/jnc.13232 pubmed: 26338675
Sanders SJ et al (2012) De novo mutations revealed by whole exome sequencing are strongly associated with autism. Nature 485:237. https://doi.org/10.1038/nature10945
doi: 10.1038/nature10945 pubmed: 22495306 pmcid: 3667984
Shao S, Xu S, Yang J, Zhang T, He Z, Sun Z, Song R (2014) A commonly carried genetic variant, rs9616915, in SHANK3 gene is associated with a reduced risk of autism spectrum disorder: replication in a Chinese population. Mol Biol Rep 41:1591–1595. https://doi.org/10.1007/s11033-013-3005-5
doi: 10.1007/s11033-013-3005-5 pubmed: 24398551
Sheng M, Kim E (2000) The Shank family of scaffold proteins. J Cell Sci 113:1851–1856
pubmed: 10806096
Shin W-H, Lee GR, Heo L, Lee H, Seok C (2014) Prediction of protein structure and interaction by GALAXY protein modeling programs. J Biodesign 2:1–11
Sigrist CJ et al (2012) New and continuing developments at PROSITE. Nucleic Acids Res 41:D344–D347. https://doi.org/10.1093/nar/gks1067
doi: 10.1093/nar/gks1067 pubmed: 23161676 pmcid: 3531220
Tang H, Thomas P (2016) PANTHER-PSEP: predicting disease-causing genetic variants using position-specific evolutionary preservation. Bioinformatics 32:2230–2232. https://doi.org/10.1093/bioinformatics/btw222
doi: 10.1093/bioinformatics/btw222 pubmed: 27193693
Vaser R, Adusumalli S, Leng SN, Sikic M, Ng P (2016) SIFT missense predictions for genomes. Nat Protocols 11:1. https://doi.org/10.1038/nprot.2015.123
doi: 10.1038/nprot.2015.123 pubmed: 26633127
Wiederstein M, Sippl MJ (2007) ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteins. Nucleic Acids Res 35:407–410. https://doi.org/10.1093/nar/gkm290
doi: 10.1093/nar/gkm290
WM M (1994) Diagnostic and statistical manual of mental disorders. Fourth edn. Am Psychiatric Assoc
Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y (2015) The I-TASSER suite: protein structure and function prediction. Nat Methods 12:7. https://doi.org/10.1038/nmeth.3213
doi: 10.1038/nmeth.3213 pubmed: 25549265 pmcid: 25549265
Zhang Y, Skolnick J (2004) Scoring function for automated assessment of protein structure template quality. Proteins 57:702–710. https://doi.org/10.1002/prot.20264
doi: 10.1002/prot.20264 pubmed: 15476259
Zhao Q et al (2014) GPS-SUMO: a tool for the prediction of sumoylation sites and SUMO-interaction motifs. Nucleic Acids Res 42:325–330. https://doi.org/10.1093/nar/gku383
doi: 10.1093/nar/gku383
Zhao Y et al (2016) The single nucleotide polymorphism study on the SHANK3 and NLGN3 gene in association with autism in Wenzhou children. Int J Clin Exp Pathol 9:5694–5699

Auteurs

Hajar Owji (H)

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, P.O. Box 71345-1583, Shiraz, Iran.

Mahboobeh Eslami (M)

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.

Navid Nezafat (N)

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. n_nezafat@sums.ac.ir.
Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, P.O. Box 71345-1583, Shiraz, Iran. n_nezafat@sums.ac.ir.

Younes Ghasemi (Y)

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. ghasemiy@sums.ac.ir.
Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, P.O. Box 71345-1583, Shiraz, Iran. ghasemiy@sums.ac.ir.
Biotechnology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. ghasemiy@sums.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH